United States

Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Aurinia Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aurinia Pharmaceuticals Inc (AUP-T)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Sep 2016 Thomson Reuters Stock Report 11 $25.00

"The Economy Matters" Report for AUP: the economy's impact on AUP's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

26 Sep 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for AUPH

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

25 Sep 2016 ValuEngine, Inc. 11 $25.00

Aurinia Pharmaceuticals

24 Sep 2016 S&P Capital IQ Quantitative Report 11 $127.00


"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

24 Sep 2016 Pechala's Reports 2 $25.00

Aurinia Pharmaceuticals Inc: Downgraded to Average

22 Sep 2016 Sadif Analytics Prime 3 $10.00

Wright Investors Service Comprehensive Report for Aurinia Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

31 Aug 2016 Wright Reports 65 $75.00

Company Snapshot - Aurinia Pharmaceuticals Inc

A director at Aurinia Pharmaceuticals Inc bought 211,865 shares at 2.360USD and the significance rating of the trade was 69/1...

28 Jun 2016 Directors Deals Ltd. 1 $12.00

Aurinia Pharmaceuticals Inc: Downgraded to Above Average

16 May 2016 Sadif Analytics Prime 3 $10.00